Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A47596 | 6604294 | Q J Med | Alcoholic liver disease in Scotland and northeastern England: presenting features in 510 patients. | 1983 | Details |
| A47598 | 6345169 | Eur Surg Res | Effects on the exocrine and endocrine pancreas of duct occlusion with two different tissue glues in the rat. | 1983 | Details |
| A47623 | 34873141 | Am J Case Rep | Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Factors. | 2021 | Details |
| A47651 | 34247393 | Aliment Pharmacol Ther | Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma. | 2021 | Details |
| A47652 | 34217877 | Clin Gastroenterol Hepatol | Prevalence and Financial Burden of Digestive Diseases in a Commercially Insured Population. | 2021 | Details |
| A47670 | 33952610 | Drug Metab Dispos | Evaluation of the Absorption, Metabolism, and Excretion of a Single Oral 1-mg Dose of Tropifexor in Healthy Male Subjects and the Concentration Dependence of Tropifexor Metabolism. | 2021 | Details |
| A47679 | 33778934 | Clin Pharmacokinet | Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide. | 2021 | Details |
| A47691 | 33631374 | Cell Mol Gastroenterol Hepatol | Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice. | 2021 | Details |
| A47710 | 33163830 | Hepatol Commun | Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis. | 2020 | Details |
| A47735 | 32730231 | JCI Insight | Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. | 2020 | Details |
| A47750 | 32555455 | Nature | A metabolic pathway for bile acid dehydroxylation by the gut microbiome. | 2020 | Details |
| A47762 | 32340652 | Gene Expr | Immune Checkpoint Inhibitors in Hepatocellular Cancer: Current Understanding on Mechanisms of Resistance and Biomarkers of Response to Treatment. | 2020 | Details |
| A47785 | 31973190 | Nutrients | Current Knowledge about the Effect of Nutritional Status, Supplemented Nutrition Diet, and Gut Microbiota on Hepatic Ischemia-Reperfusion and Regeneration in Liver Surgery. | 2020 | Details |
| A47787 | 31934485 | Case Rep Surg | Familial Adenomatous Polyposis and Desmoid Tumor Treated with Multivisceral Transplantation and Kidney Autotransplantation: Case Report and Literature Review. | 2019 | Details |
| A47790 | 33644676 | J Can Assoc Gastroenterol | Prevalence of Celiac Disease in Patients with Primary Biliary Cholangitis. | 2020 | Details |
| A47824 | 31301451 | Clin Gastroenterol Hepatol | Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients. | 2019 | Details |
| A47865 | 30660572 | Am J Med | Anticoagulation Therapy in Patients with Liver Cirrhosis is Associated With an Increased Risk of Variceal Hemorrhage. | 2019 | Details |
| A47881 | 30141927 | J Med Chem | Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5). | 2018 | Details |
| A47889 | 30004270 | J Laparoendosc Adv Surg Tech A | Preoperative Evaluation in Bariatric Surgery. | 2018 | Details |
| A47891 | 29974003 | Case Reports Hepatol | Rupture of Hepatocellular Carcinoma after Transarterial Chemoembolization followed by Massive Gastric Bleeding. | 2018 | Details |
| A47896 | 29870275 | Diabetes Technol Ther | The Clinical Impact of GLP-1 Receptor Agonists in Type 2 Diabetes: Focus on the Long-Acting Analogs. | 2018 | Details |
| A47903 | 29619419 | Hepatol Commun | Tumor necrosis factor-α-mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice. | 2018 | Details |
| A47940 | 28702877 | Eur J Drug Metab Pharmacokinet | Absorption, Distribution, Metabolism, and Excretion of [14C]-Volixibat in Healthy Men: Phase 1 Open-Label Study. | 2018 | Details |
| A47942 | 28701219 | Radiat Oncol | Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma. | 2017 | Details |
| A47943 | 28696510 | Hepatology | Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. | 2017 | Details |
| A47955 | 28321568 | Clin Rheumatol | Gastrointestinal and liver lesions in primary childhood Sjögren syndrome. | 2017 | Details |
| A47990 | 27110066 | Mediators Inflamm | Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control. | 2016 | Details |
| A48003 | 26811456 | Proc Natl Acad Sci U S A | Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis. | 2016 | Details |
| A48018 | 26447154 | Am J Clin Nutr | α-Tocopherol bioavailability is lower in adults with metabolic syndrome regardless of dairy fat co-ingestion: a randomized, double-blind, crossover trial. | 2015 | Details |
| A48065 | 27278026 | J Med Ultrason (2001) | Real-time tissue elastography (RTE) for noninvasive evaluation of fibrosis in liver diseases in children in comparison to liver biopsy. | 2014 | Details |
| A48083 | 24602085 | Ann N Y Acad Sci | Gastrointestinal morbidity in obesity. | 2014 | Details |
| A48127 | 22333480 | J Pharmacol Sci | Multiple mechanisms for the action of chymase inhibitors. | 2012 | Details |
| A48144 | 21504525 | Transpl Infect Dis | Weissella confusa bacteremia in a liver transplant patient with hepatic artery thrombosis. | 2010 | Details |
| A48151 | 21211565 | Pharmacol Res | Tissue-specific function of farnesoid X receptor in liver and intestine. | 2011 | Details |
| A48158 | 21076986 | J Hepatobiliary Pancreat Sci | Pancreaticoduodenectomies with a duct-to-mucosa pancreaticojejunostomy anastomosis with and without a stenting tube showed no differences in long-term follow-up. | 2011 | Details |
| A48177 | 20655032 | Surg Obes Relat Dis | Surgical management of gastric varices and morbid obesity: a novel approach. | 2010 | Details |
| A48231 | 19145826 | Lik Sprava | [Clinical and biochemical characteristics of clinical course and management of patients with chronic nonalcoholic steatohepatitis in combination with intestinal diseases]. | 2009 | Details |
| A48239 | 18989143 | Eur J Gastroenterol Hepatol | Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis. | 2008 | Details |
| A48245 | 18941030 | JPEN J Parenter Enteral Nutr | An evaluation of the model for end-stage liver disease and serum C-reactive protein as prognostic markers in intestinal failure patients on parenteral nutrition. | 2008 | Details |
| A48253 | 18467918 | Eur J Gastroenterol Hepatol | Severe jaundice following treatment with ezetimibe. | 2008 | Details |
| A48291 | 17323000 | J Gastroenterol | Treatment of bleeding stomal varices by balloon-occluded retrograde transvenous obliteration. | 2007 | Details |
| A48300 | 17023937 | Curr Opin Gastroenterol | Obesity: effects on the liver and gastrointestinal system. | 1999 | Details |
| A48302 | 17023554 | Am J Physiol Gastrointest Liver Physiol | Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. | 2006 | Details |
| A48323 | 16614996 | Dig Dis Sci | The association of Streptococcus bovis bacteremia and gastrointestinal diseases: a retrospective analysis. | 2006 | Details |
| A48358 | 15368170 | Dtsch Med Wochenschr | [Nonalcoholic steatohepatitis (NASH): therapeutic approaches]. | 2004 | Details |
| A48445 | 10589386 | Curr Opin Clin Nutr Metab Care | Obesity: effects on the liver and gastrointestinal system. | 1999 | Details |
| A48497 | 441676 | Scand J Gastroenterol | Carcinoembryonic antigen (CEA) in patients with alcoholic liver diseases. | 1979 | Details |
| A48523 | 34904513 | Scand J Gastroenterol | The relationship between portal hypertension and portal hypertensive gastropathy. | 2021 | Details |
| A48524 | 34887405 | Nat Commun | CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease. | 2021 | Details |
| A48529 | 34672164 | Minerva Med | SARS-CoV-2, alcohol consumption and liver injury. | 2021 | Details |
| A48549 | 34267725 | Front Endocrinol (Lausanne) | Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of Semaglutide. | 2021 | Details |
| A48595 | 33408109 | BMJ Case Rep | Recurrent haematochezia in an 85-year-old man with hepatocellular carcinoma. | 2021 | Details |
| A48602 | 33235462 | Onco Targets Ther | Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma. | 2020 | Details |
| A48611 | 33116742 | Clin Exp Gastroenterol | Erratum: Gut Dysbiosis and Increased Intestinal Permeability Drive microRNAs, NLRP-3 Inflammasome and Liver Fibrosis in a Nutritional Model of Non-Alcoholic Steatohepatitis in Adult Male Sprague Dawley Rats [Erratum]. | 2020 | Details |
| A48641 | 32582143 | Front Immunol | The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health. | 2020 | Details |
| A48643 | 32564086 | Int Immunol | The impact of metabolites derived from the gut microbiota on immune regulation and diseases. | 2020 | Details |
| A48661 | 32051033 | Microbiome | Self-reinoculation with fecal flora changes microbiota density and composition leading to an altered bile-acid profile in the mouse small intestine. | 2020 | Details |
| A48685 | 31509430 | Am J Physiol Gastrointest Liver Physiol | Rifaximin prevents ethanol-induced liver injury in obese KK-Ay mice through modulation of small intestinal microbiota signature. | 2019 | Details |
| A48691 | 31405111 | Medicina (Kaunas) | Targeting Microbiota: What Do We Know about It at Present? | 2019 | Details |
| A48723 | 30658726 | J Hepatol | Inflammatory pathways in alcoholic steatohepatitis. | 2019 | Details |
| A48725 | 30602573 | Clin Sci (Lond) | Elafibranor interrupts adipose dysfunction-mediated gut and liver injury in mice with alcoholic steatohepatitis. | 2019 | Details |
| A48727 | 30513996 | Int J Mol Sci | Genetic and Epigenetic Modifiers of Alcoholic Liver Disease. | 2018 | Details |
| A48730 | 30448775 | Gut | Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice. | 2018 | Details |
| A48739 | 30254647 | Front Immunol | Complex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and Gut. | 2018 | Details |
| A48754 | 29687200 | Probiotics Antimicrob Proteins | Are Probiotics Effective in Targeting Alcoholic Liver Diseases? | 2019 | Details |
| A48760 | 29488575 | Rev Med Chil | [Fundal variceal bleeding treated with balloon occluded endoscopic inyection sclerotherapy. Report of two cases]. | 2017 | Details |
| A48767 | 29312947 | Front Nutr | Taheebo Polyphenols Attenuate Free Fatty Acid-Induced Inflammation in Murine and Human Macrophage Cell Lines As Inhibitor of Cyclooxygenase-2. | 2017 | Details |
| A48775 | 29159825 | Hepatology | Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. | 2018 | Details |
| A48778 | 28990365 | J Cell Mol Med | Endocannabinoid-related compounds in gastrointestinal diseases. | 2017 | Details |
| A48785 | 28770495 | Curr Infect Dis Rep | Fecal Microbiota Transplantation: Beyond Clostridium difficile. | 2017 | Details |
| A48786 | 28723981 | Arq Gastroenterol | INTESTINAL MICROBIOTA IN DIGESTIVE DISEASES. | 2017 | Details |
| A48789 | 28711599 | Biochim Biophys Acta Mol Basis Dis | Arachidonic acid sex-dependently affects obesity through linking gut microbiota-driven inflammation to hypothalamus-adipose-liver axis. | 2017 | Details |
| A48792 | 28561276 | Liver Int | Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls. | 2017 | Details |
| A48793 | 28550049 | Gut | Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. | 2017 | Details |
| A48805 | 30802391 | Klin Lab Diagn | [The chronic hepatitis under pulmonary, extra-pulmonary and abdominal tuberculosis.] | 2019 | Details |
| A48806 | 27995467 | Clin J Gastroenterol | A case of gastrojejunocolic fistula with steatohepatitis. | 2016 | Details |
| A48812 | 27774805 | Orv Hetil | [Fructose and fructose intolerance]. | 2016 | Details |
| A48845 | 26755860 | World J Gastroenterol | Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies? | 2016 | Details |
| A48872 | 25954093 | World J Gastroenterol | Role of vitamins in gastrointestinal diseases. | 2015 | Details |
| A48883 | 25746479 | Toxicol Lett | Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occludin expression and protects mice from alcoholic liver disease. | 2015 | Details |
| A48892 | 25454538 | Alcohol | Abnormal ultrastructure of intestinal epithelial barrier in mice with alcoholic steatohepatitis. | 2014 | Details |
| A48897 | 25263269 | Aliment Pharmacol Ther | Review article: the management of cirrhosis in women. | 2014 | Details |
| A48898 | 25251280 | Hepatology | Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. | 2015 | Details |
| A48907 | 24824124 | Zhonghua Gan Zang Bing Za Zhi | [TLR4 contributes to intestinal hyperpermeability in alcoholic liver disease]. | 2014 | Details |
| A48921 | 24400890 | J Cell Mol Med | The functional role of microRNAs in alcoholic liver injury. | 2014 | Details |
| A48934 | 24032513 | Mini Rev Med Chem | Triglyceride Metabolism and Hepatic Diseases. | 2013 | Details |
| A48936 | 23871536 | Alcohol | Toll-like receptor 4 increases intestinal permeability through up-regulation of membrane PKC activity in alcoholic steatohepatitis. | 2013 | Details |
| A48938 | 23848072 | Nutr Hosp | [Probiotics in liver diseases]. | 2014 | Details |
| A48940 | 23768554 | Best Pract Res Clin Gastroenterol | Diabetes, obesity and gut microbiota. | 2013 | Details |
| A48959 | 23180946 | World J Gastroenterol | Celiac disease markers in patients with liver diseases: a single center large scale screening study. | 2012 | Details |
| A48973 | 22661952 | Front Physiol | Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms. | 2012 | Details |
| A48977 | 22489261 | World J Hepatol | Human immunodeficiency virus infection and the liver. | 2012 | Details |
| A48993 | 22124143 | J Physiol | Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. | 2011 | Details |
| A48996 | 21995448 | Microb Cell Fact | Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. | 2011 | Details |
| A49002 | 21734800 | World J Gastroenterol | Probiotics in hepatology. | 2011 | Details |
| A49005 | 21604434 | Cesk Patol | [Prague Hepatology Meeting 2010--hepatopathology news]. | 2011 | Details |
| A49010 | 21463341 | Alcohol Clin Exp Res | Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. | 2011 | Details |
| A49011 | 21463335 | Alcohol Clin Exp Res | Role of intestinal circadian genes in alcohol-induced gut leakiness. | 2011 | Details |
| A49042 | 20383479 | Internist (Berl) | [Hormonal and metabolic functions of the small intestine]. | 2010 | Details |
| A49071 | 19250782 | Gastroenterol Clin Biol | [Review of the association between obesity and gastroesophageal reflux and its complications]. | 2009 | Details |